TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 3 filers reported holding TG THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,037 | -88.6% | 5,746 | -66.1% | 0.00% | -85.7% |
Q2 2023 | $420,590 | +341843.1% | 16,932 | +108.1% | 0.01% | +250.0% |
Q1 2023 | $123 | -74.9% | 8,135 | -80.4% | 0.00% | -80.0% |
Q4 2022 | $490 | -99.8% | 41,449 | -24.0% | 0.02% | +300.0% |
Q3 2022 | $323,000 | +262.9% | 54,538 | +161.3% | 0.01% | +150.0% |
Q2 2022 | $89,000 | -36.4% | 20,872 | +41.4% | 0.00% | +100.0% |
Q1 2022 | $140,000 | -34.9% | 14,763 | +30.4% | 0.00% | -75.0% |
Q4 2021 | $215,000 | -14.7% | 11,325 | +49.9% | 0.00% | -33.3% |
Q3 2021 | $252,000 | +154.5% | 7,555 | +197.2% | 0.01% | +100.0% |
Q2 2021 | $99,000 | -81.8% | 2,542 | -77.4% | 0.00% | -66.7% |
Q1 2021 | $543,000 | +46.4% | 11,256 | +57.8% | 0.01% | -18.2% |
Q4 2020 | $371,000 | +381.8% | 7,131 | +148.6% | 0.01% | +1000.0% |
Q3 2020 | $77,000 | -78.9% | 2,869 | -84.7% | 0.00% | -93.3% |
Q2 2020 | $365,000 | +36400.0% | 18,702 | +18602.0% | 0.02% | – |
Q4 2019 | $1,000 | -90.9% | 100 | -94.6% | 0.00% | -100.0% |
Q3 2019 | $11,000 | -88.8% | 1,837 | -83.7% | 0.00% | -85.7% |
Q2 2019 | $98,000 | +1860.0% | 11,275 | +798.4% | 0.01% | – |
Q4 2018 | $5,000 | -89.6% | 1,255 | -85.2% | 0.00% | -100.0% |
Q3 2018 | $48,000 | -32.4% | 8,468 | +56.0% | 0.00% | 0.0% |
Q2 2018 | $71,000 | +91.9% | 5,427 | +106.6% | 0.00% | +33.3% |
Q1 2018 | $37,000 | +1750.0% | 2,627 | +1052.2% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 228 | -56.7% | 0.00% | – |
Q4 2016 | $2,000 | +100.0% | 527 | +204.6% | 0.00% | – |
Q3 2016 | $1,000 | -95.8% | 173 | -95.5% | 0.00% | -100.0% |
Q2 2016 | $24,000 | +166.7% | 3,882 | +277.3% | 0.00% | +100.0% |
Q1 2016 | $9,000 | +12.5% | 1,029 | +45.8% | 0.00% | 0.0% |
Q4 2015 | $8,000 | -85.2% | 706 | -86.8% | 0.00% | -80.0% |
Q3 2015 | $54,000 | +237.5% | 5,349 | +467.8% | 0.01% | +400.0% |
Q2 2015 | $16,000 | -85.7% | 942 | -87.0% | 0.00% | -92.9% |
Q1 2015 | $112,000 | +194.7% | 7,250 | +198.7% | 0.01% | +250.0% |
Q4 2014 | $38,000 | +22.6% | 2,427 | -17.9% | 0.00% | +33.3% |
Q3 2014 | $31,000 | +287.5% | 2,957 | +269.2% | 0.00% | +200.0% |
Q2 2014 | $8,000 | -46.7% | 801 | -63.1% | 0.00% | -50.0% |
Q1 2014 | $15,000 | 0.0% | 2,170 | -28.5% | 0.00% | 0.0% |
Q3 2013 | $15,000 | – | 3,037 | +4961.7% | 0.00% | – |
Q2 2013 | $0 | – | 60 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |